Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Investigative Dermatology. Symposium Proceedings|October 28, 1999
Photopheresis: clinical applications and mechanism of actionA H Rook, K R Suchin, D M Kao, et al.
Cancers|July 29, 2025
Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin TreatmentAndrew V Kossenkov, Noor Dawany, Sonali Majumdar, et al.
The Journal of Clinical Investigation|April 21, 2005
Immunopathogenesis and therapy of cutaneous T cell lymphomaEllen J Kim, Stephen Hess, Stephen K Richardson, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Leukemia Research|September 28, 2005
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencingT Nagasawa, Q Zhang, P N Raghunath, et al.
The Journal of Experimental Medicine|June 5, 2003
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphomaLaszlo Kari, Andrey Loboda, Michael Nebozhyn, et al.
Leukemia & Lymphoma|July 31, 2012
Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsinYoun H Kim, Marie-France Demierre, Ellen J Kim, et al.
The Journal of Investigative Dermatology|August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndromeJessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphomaEmmanuella Guenova, Rei Watanabe, Jessica E Teague, et al.
Journal of the American Academy of Dermatology|February 19, 2013
Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapyRachel S Klein, James D Dunlop, Sara S Samimi, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Investigative Dermatology. Symposium Proceedings|October 28, 1999
Photopheresis: clinical applications and mechanism of actionA H Rook, K R Suchin, D M Kao, et al.
Cancers|July 29, 2025
Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin TreatmentAndrew V Kossenkov, Noor Dawany, Sonali Majumdar, et al.
The Journal of Clinical Investigation|April 21, 2005
Immunopathogenesis and therapy of cutaneous T cell lymphomaEllen J Kim, Stephen Hess, Stephen K Richardson, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Leukemia Research|September 28, 2005
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencingT Nagasawa, Q Zhang, P N Raghunath, et al.
The Journal of Experimental Medicine|June 5, 2003
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphomaLaszlo Kari, Andrey Loboda, Michael Nebozhyn, et al.
Leukemia & Lymphoma|July 31, 2012
Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsinYoun H Kim, Marie-France Demierre, Ellen J Kim, et al.
The Journal of Investigative Dermatology|August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndromeJessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphomaEmmanuella Guenova, Rei Watanabe, Jessica E Teague, et al.
Journal of the American Academy of Dermatology|February 19, 2013
Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapyRachel S Klein, James D Dunlop, Sara S Samimi, et al.
Pageof 19